Catena's Marketing Company has the following adjusted trial balance at the end of the current year. Cash dividends of $630 were declared at the end of the year, and 560 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2,980 in cash (for a total at the end of the year of 830 shares). These effects are included below:
Catena’s Marketing Company | ||||||||
Adjusted Trial Balance | ||||||||
End of the Current Year | ||||||||
Debit | Credit | |||||||
Cash | $ | 1,490 | ||||||
Accounts receivable | 2,330 | |||||||
Interest receivable | 290 | |||||||
Prepaid insurance | 1,630 | |||||||
Long-term notes receivable | 2,890 | |||||||
Equipment | 16,100 | |||||||
Accumulated depreciation | $ | 3,150 | ||||||
Accounts payable | 2,220 | |||||||
Dividends payable | 630 | |||||||
Accrued expenses payable | 3,850 | |||||||
Income taxes payable | 2,620 | |||||||
Unearned rent revenue | 550 | |||||||
Common Stock (830 shares) | 83 | |||||||
Additional paid-in capital | 3,447 | |||||||
Retained earnings | 3,360 | |||||||
Sales revenue | 37,740 | |||||||
Interest revenue | 180 | |||||||
Rent revenue | 820 | |||||||
Wages expense | 19,400 | |||||||
Depreciation expense | 1,760 | |||||||
Utilities expense | 310 | |||||||
Insurance expense | 790 | |||||||
Rent expense | 8,900 | |||||||
Income tax expense | 2,760 | |||||||
Total | $ | 58,650 | $ | 58,650 | ||||
Prepare the closing entry at the end of the current year. (If no entry is required for a transaction/event, select "No journal entry required" in the first account field.)
We need at least 10 more requests to produce the answer.
0 / 10 have requested this problem solution
The more requests, the faster the answer.
Catena's Marketing Company has the following adjusted trial
balance at the end of the current year. Cash dividends of $630 were
declared at the end of the year, and 600 additional shares of
common stock ($0.10 par value per share) were issued at the end of
the year for $2,400 in cash (for a total at the end of the year of
830 shares). These effects are included below:
Catena's Marketing Company Adjusted Trial Balance End of the Current Year...
Catena's Marketing Company has the following adjusted trial
balance at the end of the current year. Cash dividends of $630 were
declared at the end of the year, and 550 additional shares of
common stock ($0.10 par value per share) were issued at the end of
the year for $2,930 in cash (for a total at the end of the year of
850 shares). These effects are included below:
Catena’s Marketing Company
Adjusted Trial Balance
End of the Current Year...
Catena's Marketing Company has the following adjusted trial
balance at the end of the current year. Cash dividends of $600 were
declared at the end of the year, and 600 additional shares of
common stock ($0.10 par value per share) were issued at the end of
the year for $2,400 in cash (for a total at the end of the year of
830 shares). These effects are included below:
Catena’s Marketing Company
Adjusted Trial Balance
End of the Current Year...
Catena's Marketing Company has the following adjusted trial balance at the end of the current year. Cash dividends of $630 were declared at the end of the year, and 550 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2,200 in cash (for a total at the end of the year of 830 shares). These effects are included below: Catena's Marketing Company Adjusted Trial Balance End of the Current Year...
Check my workCheck My Work button is now enabled Item 2 Item 2 5 points Catena's Marketing Company has the following adjusted trial balance at the end of the current year. Cash dividends of $610 were declared at the end of the year, and 690 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2,890 in cash (for a total at the end of the year of 850 shares). These...
8 Catena's Marketing Company has the following adjusted trial balance at the end of the current year. Cash dividends of $630 were declared at the end of the year, and 590 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2,910 in cash for a total at the end of the year of 810 shares). These effects are included below 75 Cash Catena's Marketing Company Adjusted Trial Balance End of...
0.75 points Catena's Marketing Company has the following adjusted trial balance at the end of the current year, Cash dividends of $630 were declared at the end of the year, and 520 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2.000 in cash (for a total at the end of the year of 830 shares). These effects are included below: eBook 2,650 Catena's Marketing Company Audjusted Trial Balance End...
Catena's Marketing Company has the following adjusted trial
balance at the end of the current year. Cash dividends of $600 were
declared at the end of the year, and 640 additional shares of
common stock ($0.10 par value per share) were issued at the end of
the year for $2,930 in cash (for a total at the end of the year of
830 shares). These effects are included below:
Prepare the closing entry at the end of the current
year....
Check my workCheck My Work button is now enabledItem 5Catena's Marketing Company has the following adjusted trial balance at the end of the current year. Cash dividends of $630 were declared at the end of the year, and 650 additional shares of common stock ($0.10 par value per share) were issued at the end of the year for $2,600 in cash (for a total at the end of the year of 820 shares). These effects are included below: Catena’s Marketing CompanyAdjusted Trial...
Chapter 4
Catena's Marketing Company has the following adjusted trial
balance at the end of the current year. Cash dividends of $600 were
declared at the end of the year, and 660 additional shares of
common stock ($0.10 par value per share) were issued at the end of
the year for $2,640 in cash (for a total at the end of the year of
810 shares). These effects are included below:
Catena's Marketing Company has the following adjusted trial balance...